Quant Investing in India: The State of It, Plainly

Quant investing means the investment decision is driven by measured data and an explicit model, applied consistently, rather than by a judgement formed case by case. In India it is established and growing rather than dominant: investors meet it most visibly through factor and smart beta indices and the funds tracking them, and less visibly inside portfolio management services, alternative funds and treasury desks that run systematic processes alongside fundamental ones.

The useful thing to understand is not whether quant is winning. It is what the approach requires in this particular market, because the binding constraint in India is almost never the model. It is the data.

What counts as quant, and what does not

The word is used loosely, so it helps to separate three things that often get bundled together.

Quantitative decision making. The choice of what to hold is driven by measured characteristics and an explicit rule. This is the actual subject.

Algorithmic execution. The choice of how to place an order is handled by software. A discretionary manager can use execution algorithms, and a systematic portfolio can be traded by hand. These are independent decisions.

High frequency trading. A specialised activity centred on speed and microstructure, with little in common with a quarterly rebalanced factor portfolio beyond the word “quant”.

Most of what an ordinary Indian investor will encounter under this label sits in the first category, often at fairly low frequency: monthly, quarterly or semiannual rebalancing on published rules.

What quant investing looks like in India today

Published factor indices. Indian index providers publish factor indices covering the well-documented factor families, including value, momentum, quality, low volatility and combinations of them. Their methodology documents are public and are the clearest available statement of what a serious rule looks like: eligibility screens, the measurement windows, the scoring, weighting caps and the review calendar.

Index funds and exchange traded funds on those indices. These make a rule-based exposure buyable in one instrument. Evaluating one is a passive-vehicle exercise: expense ratio, tracking difference against the stated index, on-exchange liquidity and the size of the fund. The topic is covered further under smart beta funds in India.

Systematic portfolio management services and alternative funds. Managed products that run a defined process, sometimes purely systematic and more often systematic selection with discretionary risk oversight.

Quant overlays on fundamental desks. Increasingly common and rarely labelled as quant at all: a fundamental team that uses screening and scoring to narrow a universe, then applies research judgement to the shortlist, with systematic rules for sizing and rebalancing.

Individual investors running screens. The largest group by number, and the one where method discipline varies most.

The data realities that decide everything

If you take one thing from this article, take this section. In India, the difference between a defensible quant process and a flattering one is almost always a data question.

History depth and quality. Clean, consistently defined daily data for the broad market goes back far enough to be useful, but the further back you go the thinner and less reliable it gets, especially outside the large cap universe. A test that quietly relies on the deepest part of the sample being as clean as the recent part is testing an assumption, not a strategy.

Corporate actions. Splits, bonuses, rights issues, demergers and consolidations are frequent. Every price series has to be adjusted for them before any return is computed, and an unadjusted series produces false crashes and false spikes that will wreck a ranking. The details are covered in corporate actions and adjusted prices.

Identifier churn. Companies change names, merge, demerge and relist. Matching a company’s history across those events is unglamorous work that determines whether a long-run study is measuring one company or two.

Survivorship. Testing on today’s index membership excludes everything that was delisted, suspended or dropped, which biases results upward in a way that is invisible in the output. See survivorship bias in backtests.

Restatement and point-in-time reporting. Companies restate prior periods for legitimate reasons, and reported financials are not public on the last day of the period they describe. A model that uses today’s restated figures stamped against old dates is using information that did not exist then. The reasoning is set out in why point-in-time data matters.

Liquidity and impact. A large part of the listed universe cannot absorb meaningful order size without moving the price. Many strategies that look attractive on closing prices are simply not fillable at the size their backtest assumed.

Costs and taxes. Brokerage, exchange charges, statutory levies, spread and, in a taxable account, capital gains events all sit between a gross backtest result and a real outcome. Higher turnover strategies are affected most.

Sector and classification changes. Sector definitions and index constructions have changed over the years. A long study that uses today’s classification applied to old dates is applying a map drawn later.

The honest state of play

Three observations, stated without hype.

The methods are not secret. The core factor definitions are documented in public academic literature and in published index methodologies. There is very little proprietary insight in the definitions themselves. The differentiation is in universe construction, data handling, cost modelling and execution.

The data work is the hard part. Most of the effort in a serious quant process goes into constructing an accurate, point-in-time, survivorship-free history. It is unglamorous, it produces nothing to demonstrate, and skipping it is the most common reason a promising result fails in practice.

Adoption is real but partial. Rule-based products have grown and are now easy for ordinary investors to access, while the large majority of active equity assets in India remain discretionary. Both statements are true at once, and neither implies which will do better.

What quant investing does not give you

It does not remove judgement. Choosing the universe, the signal, the window, the threshold and the rebalance schedule is judgement. Quant moves judgement to the design stage and freezes it. It does not eliminate it.

It does not see what it does not measure. Governance failures, accounting irregularities, litigation, promoter disputes, regulatory change and business model shifts are invisible to a model until they show up in the measured inputs, which is often after the damage.

It does not make history predictive. A statistical relationship documented in a sample is a description of that sample. Market regimes change, popular signals can be arbitraged down, and factors go through long droughts. Confidence intervals are wide and honest practitioners say so.

It does not protect against overfitting. The more combinations you search, the more likely you are to find one that looks excellent purely by chance. The defence is fewer parameters, a stated rationale before testing, and holding data back, as covered in what is overfitting in backtesting.

It does not guarantee you will follow it. A rule abandoned in a drawdown delivers the pain without whatever recovery might have followed. This is a behavioural constraint, and it belongs in the design.

In Indian quant work, the model is rarely the bottleneck. The bottleneck is whether your history is the history that was actually visible at the time.

A sensible way in

If you want to understand quant investing here rather than buy into it, start with the published methodology document of a factor index and read it line by line. It will show you a complete rule written by people who had to defend it: the eligibility screens, the measurement, the caps, the review dates. Then ask what that rule cannot see. That single exercise teaches more than any number of backtests.

Related reading

• Portfolio and Backtest Metrics, Explained: the hub guide to the metrics used to judge a systematic process.
• What Is Rule-Based Investing?: what a written rule buys you, and what it costs.
• Factor Investing in India: the factor families, the evidence, and the Indian context.
• Systematic vs Discretionary Investing: the two approaches compared honestly.
• Common Backtesting Mistakes: the recurring errors behind results that do not repeat.

This article is educational. Altys Labs is not a registered research analyst or investment adviser, and nothing here is investment advice or a recommendation to buy, sell, or hold any security.